241 related articles for article (PubMed ID: 27139348)
1. Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.
Kępa L; Oczko-Grzesik B; Sobala-Szczygieł B; Boroń-Kaczmarska A
Przegl Epidemiol; 2015; 69(4):705-10, 851-5. PubMed ID: 27139348
[TBL] [Abstract][Full Text] [Related]
2. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
[TBL] [Abstract][Full Text] [Related]
3. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
[No Abstract] [Full Text] [Related]
4. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J
J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219
[TBL] [Abstract][Full Text] [Related]
5. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study.
Gyllemark P; Forsberg P; Ernerudh J; Henningsson AJ
J Neuroinflammation; 2017 Feb; 14(1):27. PubMed ID: 28148307
[TBL] [Abstract][Full Text] [Related]
7. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.
Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F
J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
10. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
[TBL] [Abstract][Full Text] [Related]
11. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].
Rupprecht TA; Lechner C; Tumani H; Fingerle V
Nervenarzt; 2014 Apr; 85(4):459-64. PubMed ID: 24682168
[TBL] [Abstract][Full Text] [Related]
12. CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings.
Borde JP; Meier S; Fingerle V; Klier C; Hübner J; Kern WV
BMC Infect Dis; 2012 Dec; 12():344. PubMed ID: 23228054
[TBL] [Abstract][Full Text] [Related]
13. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.
Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U
J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.
Bremell D; Mattsson N; Edsbagge M; Blennow K; Andreasson U; Wikkelsö C; Zetterberg H; Hagberg L
BMC Neurol; 2013 Jan; 13():2. PubMed ID: 23294475
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care testing for CXCL13 in Lyme neuroborreliosis.
Pietikäinen A; Oksi J; Hytönen J
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):226-228. PubMed ID: 29567125
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis.
Rupprecht TA; Manz KM; Fingerle V; Lechner C; Klein M; Pfirrmann M; Koedel U
Clin Microbiol Infect; 2018 Dec; 24(12):1234-1240. PubMed ID: 29674128
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid CXCL13 in non-borrelial central nervous system infections: contribution of CXCL13 to the differential diagnosis.
Smíšková D; Džupová O; Moravcová L; Pícha D
Infect Dis (Lond); 2023 Aug; 55(8):551-558. PubMed ID: 37317698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
